CareDx, Inc (CDNA)
Upgrades & Downgrades
Latest CDNA news
5 Top Stocks Cathie Wood Is Buying This Week
30 September 2022
Last week, Cathie Wood made headlines after it was announced that she would relinquish her position as portfolio manager over two of her exchange-traded funds (ETFs), the 3D Printing ETF (BATS: PRNT )...
Cathie Wood's Ark Invest Adds $7M Of Bitcoin-Focused Block Shares, Also Picks Up Some CareDx Stock
14 September 2022
Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey's Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday's closing price.
CareDx (CDNA) – Cathie Wood's Ark Invest Adds $3M In CareDx Shares Despite Bleak Q2 Results
30 August 2022
Cathie Wood-led Ark Investment Management loaded up on 153,917 shares of precision medicine company CareDx Inc (NASDAQ: CDNA), via the ARK Genomic Revolution ETF (NYSE: ARKG
CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers
8 August 2022
Which of the healthcare diagnostic services producers is now a better buy to help build your portfolio's near-term capital value? Near-term only, repetition provides long term. Find out here what the ...
CareDx, Inc. (CDNA) CEO Reg Seeto on Q2 2022 Results - Earnings Call Transcript
7 August 2022
CareDx, Inc. (NASDAQ:CDNA ) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Ian Cooney - VP, IR Reg Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants ...
CareDx, Inc (CDNA) CEO Reg Seeto on Q1 2022 Results - Earnings Call Transcript
5 May 2022
CareDx, Inc (NASDAQ:CDNA ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Ian Cooney - VP of IR Reg Seeto - CEO Ankur Dhingra - CFO Conference Call Participants Alex Nowa...
CareDx (CDNA) Reports Q1 Loss, Tops Revenue Estimates
5 May 2022
CareDx (CDNA) delivered earnings and revenue surprises of -225% and 1%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
These Charts Explain Why I'm Holding This Healthcare Company
29 April 2022
Transplants are in high demand; this company is making the process of getting one smoother.
CareDx to Report First Quarter 2022 Financial Results
27 April 2022
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differe...